GRANULES INDIA LTD.-$ - 532482 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate30-07-2021
30-07-2021
Earnings Call for Q1FY22 of Granules India
Conference Call with Granules India Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.29-07-2021
Drug firm Granules India Q1 consolidated net profit up 8% to Rs 120 cr
Drug firm Granules India on Tuesday reported an 8 per cent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 30, 2021.27-07-2021
Granules India Ltd - 532482 - Board declares First Interim Dividend
Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 27, 2021, inter alia, has declared first interim dividend of 25 paise per share of face value of Re. 1/- each representing 25% of paid-up capital for the financial year 2021-22.27-07-2021
GRANULES INDIA LTD.-$ - 532482 - Record Date For The Purpose Of Payment Of First Interim Dividend For The F.Y 2021-22.
Record Date for the purpose of payment of first interim dividend for the F.Y 2021-22.27-07-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to the Analysts/Investors on the financial results for the quarter ended June 30,2021.27-07-2021
GRANULES INDIA LTD.-$ - 532482 - Outcome Of Board Meeting Dated July 27,2021.
Outcome of Board Meeting Dated July 27,2021.27-07-2021
GRANULES INDIA LTD.-$ - 532482 - Un-Audited Financial Results For The Quarter Ended June 30,2021.
Un-audited financial results for the quarter ended June 30,2021.27-07-2021
USFDA closes observations on Granules India's arm
Earlier, it had issued two minor observations during the audit.21-07-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Pharmaceuticals, Inc. Clears US FDA Audit21-07-2021